Trial Outcomes & Findings for Erbium, Chromium: Yttrium, Scandium, Gallium, Garnet (Er,Cr:YSGG) Laser in Root Canal Disinfection (NCT NCT05959629)

NCT ID: NCT05959629

Last Updated: 2025-10-09

Results Overview

By measuring change in bacteria colony forming units (CFU) before and after treatment for the experimental group (laser) and the standard of care (NaOCl) group, then comparing the two groups.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

56 participants

Primary outcome timeframe

All samples will be taken during the first root canal treatment visit. Sample1 before cleaning or shaping the root canal.

Results posted on

2025-10-09

Participant Flow

Allocated to control: n=28, received allocated control =26. 2 when accessed were partially necrotic. Allocated to intervention: n=28, received allocated control =26. 2 had technical issues.

Participant milestones

Participant milestones
Measure
Waterlase Express™, BIOLASE®
Root canals will be instrumented up to size 30/0.04 taper using Er,Cr:YSGG laser (Waterlase Express™, BIOLASE®), followed by standard of care (NaOCl). Waterlase Express™, BIOLASE®: Er,Cr:YSGG laser 2780nm (Waterlase Express™, BIOLASE®) with 300μm tip (EdgePro #3) will be placed into the mid-root of the canal. The tip will be activated and slowly withdrawn to the orifice (1-2mm/sec) following the manufacturer settings (energy 15 Millijoule (mJ), repetition rate 50 Hertz (Hz), 0% air, 0% water).
Sodium Hypochlorite
Root canals will be instrumented up to size 30/0.04 taper using standard of care (NaOCl). Sodium Hypochlorite: Root canals will be instrumented up to size 30/0.04 taper using 1.5cc of 3% NaOCl in between files.
Overall Study
STARTED
28
28
Overall Study
COMPLETED
26
26
Overall Study
NOT COMPLETED
2
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Waterlase Express™, BIOLASE®
Root canals will be instrumented up to size 30/0.04 taper using Er,Cr:YSGG laser (Waterlase Express™, BIOLASE®), followed by standard of care (NaOCl). Waterlase Express™, BIOLASE®: Er,Cr:YSGG laser 2780nm (Waterlase Express™, BIOLASE®) with 300μm tip (EdgePro #3) will be placed into the mid-root of the canal. The tip will be activated and slowly withdrawn to the orifice (1-2mm/sec) following the manufacturer settings (energy 15 Millijoule (mJ), repetition rate 50 Hertz (Hz), 0% air, 0% water).
Sodium Hypochlorite
Root canals will be instrumented up to size 30/0.04 taper using standard of care (NaOCl). Sodium Hypochlorite: Root canals will be instrumented up to size 30/0.04 taper using 1.5cc of 3% NaOCl in between files.
Overall Study
partially necrotic/technical issues
2
2

Baseline Characteristics

participants included in the study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Waterlase Express™, BIOLASE®
n=26 Participants
Root canals will be instrumented up to size 30/0.04 taper using Er,Cr:YSGG laser (Waterlase Express™, BIOLASE®), followed by standard of care (NaOCl). Waterlase Express™, BIOLASE®: Er,Cr:YSGG laser 2780nm (Waterlase Express™, BIOLASE®) with 300μm tip (EdgePro #3) will be placed into the mid-root of the canal. The tip will be activated and slowly withdrawn to the orifice (1-2mm/sec) following the manufacturer settings (energy 15 Millijoule (mJ), repetition rate 50 Hertz (Hz), 0% air, 0% water).
Sodium Hypochlorite
n=26 Participants
Root canals will be instrumented up to size 30/0.04 taper using standard of care (NaOCl). Sodium Hypochlorite: Root canals will be instrumented up to size 30/0.04 taper using 1.5cc of 3% NaOCl in between files.
Total
n=52 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Age, Categorical
Between 18 and 65 years
26 Participants
n=93 Participants
26 Participants
n=4 Participants
52 Participants
n=27 Participants
Age, Categorical
>=65 years
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Age, Continuous
45 years
STANDARD_DEVIATION 2 • n=93 Participants
44.125 years
STANDARD_DEVIATION 2 • n=4 Participants
44.57 years
STANDARD_DEVIATION 2 • n=27 Participants
Sex: Female, Male
Female
13 Participants
n=93 Participants • participants included in the study
13 Participants
n=4 Participants • participants included in the study
26 Participants
n=27 Participants • participants included in the study
Sex: Female, Male
Male
13 Participants
n=93 Participants • participants included in the study
13 Participants
n=4 Participants • participants included in the study
26 Participants
n=27 Participants • participants included in the study
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Asian
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
White
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race (NIH/OMB)
Unknown or Not Reported
26 Participants
n=93 Participants
26 Participants
n=4 Participants
52 Participants
n=27 Participants
Region of Enrollment
United States
26 Participants
n=93 Participants
26 Participants
n=4 Participants
52 Participants
n=27 Participants

PRIMARY outcome

Timeframe: All samples will be taken during the first root canal treatment visit. Sample1 before cleaning or shaping the root canal.

By measuring change in bacteria colony forming units (CFU) before and after treatment for the experimental group (laser) and the standard of care (NaOCl) group, then comparing the two groups.

Outcome measures

Outcome measures
Measure
Waterlase Express™, BIOLASE®
n=26 Participants
Root canals will be instrumented up to size 30/0.04 taper using Er,Cr:YSGG laser (Waterlase Express™, BIOLASE®), followed by standard of care (NaOCl). Waterlase Express™, BIOLASE®: Er,Cr:YSGG laser 2780nm (Waterlase Express™, BIOLASE®) with 300μm tip (EdgePro #3) will be placed into the mid-root of the canal. The tip will be activated and slowly withdrawn to the orifice (1-2mm/sec) following the manufacturer settings (energy 15 Millijoule (mJ), repetition rate 50 Hertz (Hz), 0% air, 0% water).
Sodium Hypochlorite
n=26 Participants
Root canals will be instrumented up to size 30/0.04 taper using standard of care (NaOCl). Sodium Hypochlorite: Root canals will be instrumented up to size 30/0.04 taper using 1.5cc of 3% NaOCl in between files.
The Change in Bacterial Count Between the Experimental Group (Laser) and the Standard of Care (NaOCl) Group (Routinely Used Irrigation Protocol).
8.279923256 Mean CFU
Standard Deviation 2.933726699
8.601200494 Mean CFU
Standard Deviation 2.99841829

PRIMARY outcome

Timeframe: All samples will be taken during the first root canal treatment visit. Sample2 after cleaning and shaping of the root canal using laser or NaOCl.

By measuring change in bacteria colony forming units (CFU) before and after treatment for the experimental group (laser) and the standard of care (NaOCl) group, then comparing the two groups.

Outcome measures

Outcome measures
Measure
Waterlase Express™, BIOLASE®
n=26 Participants
Root canals will be instrumented up to size 30/0.04 taper using Er,Cr:YSGG laser (Waterlase Express™, BIOLASE®), followed by standard of care (NaOCl). Waterlase Express™, BIOLASE®: Er,Cr:YSGG laser 2780nm (Waterlase Express™, BIOLASE®) with 300μm tip (EdgePro #3) will be placed into the mid-root of the canal. The tip will be activated and slowly withdrawn to the orifice (1-2mm/sec) following the manufacturer settings (energy 15 Millijoule (mJ), repetition rate 50 Hertz (Hz), 0% air, 0% water).
Sodium Hypochlorite
n=26 Participants
Root canals will be instrumented up to size 30/0.04 taper using standard of care (NaOCl). Sodium Hypochlorite: Root canals will be instrumented up to size 30/0.04 taper using 1.5cc of 3% NaOCl in between files.
The Change in Bacterial Count Between the Experimental Group (Laser) and the Standard of Care (NaOCl) Group (Routinely Used Irrigation Protocol).
4.332058015 Mean CFU
Standard Deviation 2.154027598
4.373858908 Mean CFU
Standard Deviation 2.532760244

PRIMARY outcome

Timeframe: All samples will be taken during the first root canal treatment visit. Sample 3 Upon completion of final routine irrigation protocol.

By measuring change in bacteria colony forming units (CFU) before and after treatment for the experimental group (laser) and the standard of care (NaOCl) group, then completion of final routine irrigation protocol, then comparing the two groups.

Outcome measures

Outcome measures
Measure
Waterlase Express™, BIOLASE®
n=26 Participants
Root canals will be instrumented up to size 30/0.04 taper using Er,Cr:YSGG laser (Waterlase Express™, BIOLASE®), followed by standard of care (NaOCl). Waterlase Express™, BIOLASE®: Er,Cr:YSGG laser 2780nm (Waterlase Express™, BIOLASE®) with 300μm tip (EdgePro #3) will be placed into the mid-root of the canal. The tip will be activated and slowly withdrawn to the orifice (1-2mm/sec) following the manufacturer settings (energy 15 Millijoule (mJ), repetition rate 50 Hertz (Hz), 0% air, 0% water).
Sodium Hypochlorite
n=26 Participants
Root canals will be instrumented up to size 30/0.04 taper using standard of care (NaOCl). Sodium Hypochlorite: Root canals will be instrumented up to size 30/0.04 taper using 1.5cc of 3% NaOCl in between files.
The Change in Bacterial Count Between the Experimental Group (Laser) and the Standard of Care (NaOCl) Group (Routinely Used Irrigation Protocol).
2.765533576 Mean CFU
Standard Deviation 2.087467581
2.570435011 Mean CFU
Standard Deviation 2.413322255

SECONDARY outcome

Timeframe: At the end of the first root canal treatment visit, patients will be given a survey and asked to rate the intensity of preoperative pain and postoperative pain at 4-hours post treatment

Following a previous published study done at the Department of Endodontics, University of Pennsylvania. Patients will be asked to rate the intensity of preoperative pain on a numeric rating scale (NRS) from 0 (no pain) to 10 (worst pain) before receiving root canal treatment. Along with NRS, the Wong-Baker facial grimace scale (images) will also be presented to the patients to help them in scoring the pain. Patients will be asked to rate the intensity of postoperative pain at 4-hours after the procedure. Change = (4 hours score - baseline score)

Outcome measures

Outcome measures
Measure
Waterlase Express™, BIOLASE®
n=26 Participants
Root canals will be instrumented up to size 30/0.04 taper using Er,Cr:YSGG laser (Waterlase Express™, BIOLASE®), followed by standard of care (NaOCl). Waterlase Express™, BIOLASE®: Er,Cr:YSGG laser 2780nm (Waterlase Express™, BIOLASE®) with 300μm tip (EdgePro #3) will be placed into the mid-root of the canal. The tip will be activated and slowly withdrawn to the orifice (1-2mm/sec) following the manufacturer settings (energy 15 Millijoule (mJ), repetition rate 50 Hertz (Hz), 0% air, 0% water).
Sodium Hypochlorite
n=26 Participants
Root canals will be instrumented up to size 30/0.04 taper using standard of care (NaOCl). Sodium Hypochlorite: Root canals will be instrumented up to size 30/0.04 taper using 1.5cc of 3% NaOCl in between files.
Mean Change From Baseline in Pain Scores at 4-hours After the Procedure on a Numeric Rating Scale (NRS)
t0
3.28 units on a scale
Standard Deviation 3.67
2.38 units on a scale
Standard Deviation 3.68
Mean Change From Baseline in Pain Scores at 4-hours After the Procedure on a Numeric Rating Scale (NRS)
t4
3.32 units on a scale
Standard Deviation 2.67
2.67 units on a scale
Standard Deviation 2.66

SECONDARY outcome

Timeframe: At the end of the first root canal treatment visit, patients will be given a survey and asked to rate the postoperative pain at 24-hours post treatment

Following a previous published study done at the Department of Endodontics, University of Pennsylvania. Patients will be asked to rate the intensity of preoperative pain on a numeric rating scale (NRS) from 0 (no pain) to 10 (worst pain) before receiving root canal treatment. Along with NRS, the Wong-Baker facial grimace scale (images) will also be presented to the patients to help them in scoring the pain. Patients will be asked to rate the intensity of postoperative pain at 24-hours after the procedure. Change = (24 hours score - baseline score)

Outcome measures

Outcome measures
Measure
Waterlase Express™, BIOLASE®
n=26 Participants
Root canals will be instrumented up to size 30/0.04 taper using Er,Cr:YSGG laser (Waterlase Express™, BIOLASE®), followed by standard of care (NaOCl). Waterlase Express™, BIOLASE®: Er,Cr:YSGG laser 2780nm (Waterlase Express™, BIOLASE®) with 300μm tip (EdgePro #3) will be placed into the mid-root of the canal. The tip will be activated and slowly withdrawn to the orifice (1-2mm/sec) following the manufacturer settings (energy 15 Millijoule (mJ), repetition rate 50 Hertz (Hz), 0% air, 0% water).
Sodium Hypochlorite
n=26 Participants
Root canals will be instrumented up to size 30/0.04 taper using standard of care (NaOCl). Sodium Hypochlorite: Root canals will be instrumented up to size 30/0.04 taper using 1.5cc of 3% NaOCl in between files.
Secondary Outcome: Mean Change From Baseline in Pain Scores at 24 Hours After the Procedure on a Numeric Rating Scale (NRS).
2.16 score on a scale
Standard Deviation 2.62
1.13 score on a scale
Standard Deviation 1.92

SECONDARY outcome

Timeframe: At the end of the first root canal treatment visit, patients will be given a survey and asked to rate the postoperative pain at 48-hours post treatment

Following a previous published study done at the Department of Endodontics, University of Pennsylvania. Patients will be asked to rate the intensity of preoperative pain on a numeric rating scale (NRS) from 0 (no pain) to 10 (worst pain) before receiving root canal treatment. Along with NRS, the Wong-Baker facial grimace scale (images) will also be presented to the patients to help them in scoring the pain. Patients will be asked to rate the intensity of postoperative pain at 48-hours after the procedure. Change = (48 hours score - baseline score)

Outcome measures

Outcome measures
Measure
Waterlase Express™, BIOLASE®
n=26 Participants
Root canals will be instrumented up to size 30/0.04 taper using Er,Cr:YSGG laser (Waterlase Express™, BIOLASE®), followed by standard of care (NaOCl). Waterlase Express™, BIOLASE®: Er,Cr:YSGG laser 2780nm (Waterlase Express™, BIOLASE®) with 300μm tip (EdgePro #3) will be placed into the mid-root of the canal. The tip will be activated and slowly withdrawn to the orifice (1-2mm/sec) following the manufacturer settings (energy 15 Millijoule (mJ), repetition rate 50 Hertz (Hz), 0% air, 0% water).
Sodium Hypochlorite
n=26 Participants
Root canals will be instrumented up to size 30/0.04 taper using standard of care (NaOCl). Sodium Hypochlorite: Root canals will be instrumented up to size 30/0.04 taper using 1.5cc of 3% NaOCl in between files.
Mean Change From Baseline in Pain Scores at 48-hours After the Procedure on a Numeric Rating Scale (NRS)
1.44 score on a scale
Standard Deviation 0.58
2.20 score on a scale
Standard Deviation 1.50

SECONDARY outcome

Timeframe: Periapical bone changes measured at baseline and 6 months follow up (± 7 days) post root canal filling.

Population: The study was terminated. Data were not collected for this measure at any time point. Unable to follow up participants due to their geographic location and other reasons.

Periapical radiographs will be taken at baseline (preoperative) then at 6 months follow up post root canal filling Radiographically, Following periapical index (PAI) by Órstavik 1986, description of radiographic findings: 1. Normal periapical structures. 2. Small changes in the bone structure. 3. Change in the bone structure with mineral loss. 4. Periodontitis with a well-defined radiolucent area. 5. Severe periodontitis with exacerbating features. Success is defined as either complete (radiographic resolution of a periapical lesion - the radiographic sign of inflammatory processes surrounding a root tip) or incomplete healing (scar tissue formation) and failure includes uncertain healing (radiographic reduction of a periapical lesion or same lesion size) or unsatisfactory healing (increase in lesion size) as determined on the radiograph.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Periapical bone changes measured at baseline and 1 year follow up (± 7 days) post root canal filling.

Population: The study was terminated. Data were not collected for this measure at any time point. Unable to follow up participants due to their geographic location and other reasons.

Periapical radiographs will be taken at baseline (preoperative) then at 1 year follow up post root canal filling Radiographically, Following periapical index (PAI) by Órstavik 1986, description of radiographic findings: 1. Normal periapical structures. 2. Small changes in the bone structure. 3. Change in the bone structure with mineral loss. 4. Periodontitis with a well-defined radiolucent area. 5. Severe periodontitis with exacerbating features. Success is defined as either complete (radiographic resolution of a periapical lesion - the radiographic sign of inflammatory processes surrounding a root tip) or incomplete healing (scar tissue formation) and failure includes uncertain healing (radiographic reduction of a periapical lesion or same lesion size) or unsatisfactory healing (increase in lesion size) as determined on the radiograph.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Periapical bone changes measured at baseline and 2 years follow up (± 7 days) post root canal filling.

Population: The study was terminated. Data were not collected for this measure at any time point. Unable to follow up participants due to their geographic location and other reasons.

Periapical radiographs will be taken at baseline (preoperative) then at 2 years follow up post root canal filling Radiographically, Following periapical index (PAI) by Órstavik 1986, description of radiographic findings: 1. Normal periapical structures. 2. Small changes in the bone structure. 3. Change in the bone structure with mineral loss. 4. Periodontitis with a well-defined radiolucent area. 5. Severe periodontitis with exacerbating features. Success is defined as either complete (radiographic resolution of a periapical lesion - the radiographic sign of inflammatory processes surrounding a root tip) or incomplete healing (scar tissue formation) and failure includes uncertain healing (radiographic reduction of a periapical lesion or same lesion size) or unsatisfactory healing (increase in lesion size) as determined on the radiograph.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Clinical signs and symptoms measured at 6 months (± 7 days) post root canal filling.

Population: The study was terminated. Data were not collected for this measure at any time point. Unable to follow up participants due to their geographic location and other reasons.

Clinical signs and symptoms: Pain, swelling, percussion sensitivity and sinus tracts measured at 6 months follow up. Clinically success is defined by the absence of pain, swelling, percussion sensitivity or sinus tracts. Clinical failure is defined as the persistent presence of any of the signs and symptoms mentioned above.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Clinical signs and symptoms measured at 1 year (± 7 days) post root canal filling.

Population: The study was terminated. Data were not collected for this measure at any time point. Unable to follow up participants due to their geographic location and other reasons.

Clinical signs and symptoms: Pain, swelling, percussion sensitivity and sinus tracts measured at 1 year follow up. Clinically success is defined by the absence of pain, swelling, percussion sensitivity or sinus tracts. Clinical failure is defined as the persistent presence of any of the signs and symptoms mentioned above.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Clinical signs and symptoms measured at 2 years (± 7 days) post root canal filling.

Population: The study was terminated. Data were not collected for this measure at any time point. Unable to follow up participants due to their geographic location and other reasons.

Clinical signs and symptoms: Pain, swelling, percussion sensitivity and sinus tracts measured at 2 years follow up. Clinically success is defined by the absence of pain, swelling, percussion sensitivity or sinus tracts. Clinical failure is defined as the persistent presence of any of the signs and symptoms mentioned above.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured at 6 months (± 7 days) post root canal filling.

Population: The study was terminated. Data were not collected for this measure at any time point. Unable to follow up participants due to their geographic location and other reasons.

Tooth survival is defined as the presence of the tooth inside the mouth. Success: Tooth is still present in the oral cavity. Failure: Tooth is extracted for any reason.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured at 1 year (± 7 days) post root canal filling.

Population: The study was terminated. Data were not collected for this measure at any time point. Unable to follow up participants due to their geographic location and other reasons.

Tooth survival is defined as the presence of the tooth inside the mouth. Success: Tooth is still present in the oral cavity. Failure: Tooth is extracted for any reason.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured at 2 years (± 7 days) post root canal filling.

Population: The study was terminated. Data were not collected for this measure at any time point. Unable to follow up participants due to their geographic location and other reasons.

Tooth survival is defined as the presence of the tooth inside the mouth. Success: Tooth is still present in the oral cavity. Failure: Tooth is extracted for any reason.

Outcome measures

Outcome data not reported

Adverse Events

Waterlase Express™, BIOLASE®

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Sodium Hypochlorite

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Bekir Karabucak

University of Pennsylvania School of Dental Medicine

Phone: 215-898-4927

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place